PAUL Y. HOLOYE, M.D.; MARIO A. LUNA, M.D.; BRUCE MacKAY, M.D.; CARLOS W. M. BEDROSSIAN, M.D.
Three patients developed radiologic and functional pulmonary changes after bleomycin therapy similar to ones previously associated with administration of this drug. However, biopsy specimens showed a pattern consistent with hypersensitivity pneumonitis rather than the interstitial pneumonia usually reported in bleomycin pulmonary toxicity. There was a patchy eosinophilic infiltrate surrounding small airways and distal air spaces, but no immune deposits were noted by ultrastructure or immunofluorescence using conventional techniques and a specific antibody against bleomycin. Two of the patients had peripheral eosinophilia of 12% and 16%. All three patients showed considerable improvement on chest roentgenogram after corticosteroid treatment. Our findings are consistent with the view that bleomycin hypersensitivity pneumonitis has a different pathogenesis than bleomycin interstitial pneumonitis. Its recognition as a separate entity seems warranted because of the favorable response to steroid therapy.
HOLOYE PY, LUNA MA, MacKAY B, BEDROSSIAN CWM. Bleomycin Hypersensitivity Pneumonitis. Ann Intern Med. ;88:47–49. doi: 10.7326/0003-4819-88-1-47
Download citation file:
Published: Ann Intern Med. 1978;88(1):47-49.
Interstitial Lung Disease, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use